Bayerische Akademie der Wissenschaften BAdW_Fahnen_2019_BAdW_Fahnen_2019_(c)S.Obermeier

Awards & Grants, Environmental Health, IAP, Molecular Targets and Therapeutics, VIRO,

Erika von Mutius and Ulrike Protzer Elected to Bavarian Academy

At its most recent plenary session, the Bavarian Academy of Sciences and Humanities (BAdW) elected 14 distinguished scholars as new members. Among them are two Helmholtz Munich researchers: Prof. Erika von Mutius and Prof. Ulrike Protzer.

Eppstein Barr Virus

Transfer, New Research Findings, Molecular Targets and Therapeutics,

Start-up EBViously founded

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious…

Schmoller Lab Cell-ACDC - Kurt Schmoller P1215367

Awards & Grants, Molecular Targets and Therapeutics, IFE,

ERC Consolidator Grant Awarded to Kurt Schmoller for Mitochondrial DNA Research

Dr. Kurt Schmoller from the Institute of Functional Epigenetics at Helmholtz Munich has been awarded a prestigious European Research Council (ERC) Consolidator Grant. This significant recognition supports outstanding mid-career researchers in…

Apoptosis process in a cell

Molecular Targets and Therapeutics, MCD,

Ferroptosis: Controlling Life or Death of Cells

Cell death is indispensable to life, as it ensures the removal of damaged or unnecessary cells. Among the many ways a cell can die, ferroptosis is a unique and regulated form of cell death. This process plays a significant role in the pathogenesis of…

Porträt: Marcus Conrad Querformat Indoor HDC

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Award-Winning Ferroptosis Expert Marcus Conrad

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, was awarded the ECDO Honorary Award 2024 for his pioneering research on ferroptosis. He has been a Professor at the Technical University of Munich (TUM)…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, MCD,

Novel Selenium Carrier Protein Regulates Ferroptosis in Cancer and Brain

Researchers at Helmholtz Munich have identified a specific redox protein as a critical regulator of ferroptosis - a form of regulated oxidative cell death. Research into ferroptosis mechanisms has attracted considerable interest due to its potential…